WHS01 : Sao Paulo (USP) – Chikungunya and Zika virus infections as global Public Health challenges

WHS01 : Sao Paulo (USP) – Chikungunya and Zika virus infections as global Public Health challenges

Location: Room 2 Date: April 19, 2016 Time: 11:00 am - 12:30 pm


Zika virus is a mosquito-transmitted Flavivirus currently spreading throughout the Americas. After being first identified in northeastern Brazil in May 2015, the infection rapidly disseminated and, as for February 2016, authoctonoustransmission had been reported in 31 Latin American and Caribbean countries. Initially thought to be associated with a minor febrile illness, there is increasing evidence of associations with potentially severe neurologic complications, such as Guillain-Barré Syndrome and congenital anomalies, including microcephaly. Several questions still challenge national and international efforts to control the spread of this flaviral infection and to manage infected individuals. The panel will discuss the context surrounding the introduction of zikavirus in South America, a region where the Aedes aegypti vector is widespread, dengue epidemics have dramatically impacted healthcare provision, and where the chikungunya virus had been recently introduced. Diagnostic challenges in these circumstances will be discussed and the current evidence of the association between zikavirus infection and microcephaly thoroughly reviewed.


Laurent Kaiser

Laurent Kaiser

ID Name of the moderator Organisation Country
WHS1/0 HUG Switzerland


ID Title of the presentation Name of the speaker Organisation Country
WHS1/1 Emerging vector-borne infections in dengue-affected regions - lessons learned in Brazil Aluisio Segurado

International Affairs Commit- tee, School of Medicine, Uni- versity of São Paulo

WHS1/2 New developments in diagnosis and prevention of vector-borne viral infections Ester Sabino

Institute of Tropical Medicine, Department of Infectious Dis- ease, University of Sao Paulo Medical School

WHS1/3 Zika virus infection and microcephaly - what is the evidence? Laura Rodrigues

Tropical Medicine (LSHTM) and the Microcephaly Epidemic Research Group (MERG)

UK and Brazil